Abstract
Insights into the function of the Golgi complex have been provided by experiments performed with various inhibitors of membrane trafficking, such as the macrocyclic lactone brefeldin A (BFA), a compound that inhibits constitutive secretion, prevents the formation of coatomer-coated transport vesicles, and stimulates the retrograde movement of Golgi resident enzymes back to the ER. We show here that the structurally unrelated compound clofibrate, a peroxisome proliferator (PP) and hypolipidemic agent, also reversibly disrupts the morphological and functional integrity of the Golgi complex in a manner similar to BFA. In the presence of clofibrate, the forward transport of newly synthesized secretory proteins from the ER to the Golgi is dramatically inhibited. Moreover, clofibrate causes Golgi membranes to travel rapidly in a microtubule-dependent manner back to the ER, forming a hybrid ER–Golgi tubulovesicular membrane network. These affects appear to be independent of clofibrate's ability to stimulate the PP-activated receptor (PPAR) alpha pathway because other PPAR stimulators (DEHP, WY-14643) did not alter the Golgi complex or induce retrograde trafficking. These data suggest that PPAR alpha-independent, clofibrate-sensitive proteins participate in regulating Golgi-to-ER retrograde membrane transport, and, equally importantly, that clofibrate may be used as a pharmacological tool for investigating Golgi membrane dynamics.
Similar content being viewed by others
References
Catapano AL. Mode of action of fibrates. Pharm Res. 1992;26:331–40.
Cole NB, Lippincott-Schwartz J. Organization of organelles and membrane traffic by microtubules. Curr Opin Cell Biol. 1995;7:55–64.
Davidson HW, Balch WE. Use of two-stage incubations to define sequential intermediates in endoplasmic reticulum to Golgi transport. Methods Enzymol. 1992;219:261–7.
Dashti N, Ontko JA. Alteration in rat serum lipids and apolipoproteins following clofibrate treatment. Atherosclerosis. 1983;49:255–66.
de Figueriedo P, Drecktrah D, Katzenellenbogen J, Strang M, Brown WJ. Evidence that phospholipase A2 (PLA2) activity is required for Golgi complex and TGN membrane tubulation. Proc Natl Acad Sci USA. 1998;95:8642–7.
de Figueriedo P, Polizotto RS, Drecktrah D, Brown WJ. Membrane tubule-mediated reassembly and maintenance of the Golgi complex is disrupted by phospholipase A2 antagonists. Mol Biol Cell. 1999;10:1763–82.
Dinter A, Berger EG. Golgi-disturbing agents. Histochem Cell Biol. 1998;109:571–90.
Doms RW, Russ G, Yewdell JW. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol. 1989;109:61–72.
Donaldson JG, Lippincott-Schwartz J, Bloom GS, Kreis TE, Klausner RD. Dissociation of a 110-kD peripheral membrane protein from the Golgi apparatus is an early event in brefeldin A action. J Cell Biol. 1990;111:2295–306.
Donaldson JG, Kahn RA, Lippincott-Schwartz J, Klausner RD. Binding of ARF and β-COP to Golgi membranes: possible regulation by a trimeric G protein. Science. 1991;254:1197–9.
Fujiwara T, Oda K, Yokota S, Takasuki A, Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem. 1988;269:18545–52.
Gonzalez FJ, Peters JM, Cattley RC. Mechanisms of action of the nongenotoxic peroxisome proliferators: role of the peroxisome preliferator-activator receptor-alpha. J Natl Cancer Inst. 1998;90:1702–9.
Hahn SE, Goldberg DM. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate. Biochem Pharmacol. 1992;43:625–33.
Heshimati HM, Turpin G, Touitou Y et al. A lack of effect in vivo of clofibrate on adrenal steroid secretion. Eur J Clin Pharmacol. 1989:36:87–9.
Hunziker W, Whitney JA, Mellman I. Selective inhibition of transcytosis by brefeldin A in MDCK cells. Cell. 1991;67:617–27.
Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: Insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992;116:1071–80.
Knipe DM, Baltimore D, Lodish HF. Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol. 1997;21:1149–58.
Kobayashi I, Shimomura Y, Maruta S et al. Clofibrate and a related compound suppress TSH secretion in primary hypothyroidism. Acta Endocrinol. 1980;94:53–7.
Lewis MJ, Turco SJ, Green M. Structure and assembly of the endoplasmic reticulum. Biosynthetic sorting of endoplasmic reticulum proteins. J Biol Chem. 1985;260:6926–31.
Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane recycling from the Golgi to ER. Cell. 1989;56:801–13.
Lippincott-Schwartz J, Donaldson JG, Schweizer A et al. Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell. 1990;60:821–36.
Lippincott-Schwartz J, Yuan LC, Tipper C, Amherdt M, Orci L, Klausner RD. Brefeldin A's effect on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell. 1991;67:601–17.
Mallabiabarrena A, Malhotra V. Vesicle biogenesis: the coat connection. Cell. 1995;83:667–9.
Mellman I, Simon K. The Golgi complex: in vitro veritas? Cell. 1992;68:829–40.
Misumi Y, Miki K, Takasuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem. 1986; 261:11398–403.
Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem. 1986;55:69–102.
Neele DM, Kaptein A, Huisman H, de Wit EC, Princen HM. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased. Biochem Biophys Res Commun. 1998;244:374–8.
Oda K, Hirose S, Takami N, Misumi A, Takasuki A, Ikehara Y. Brefeldin A arrests the intracellular transport of a precursor of complement C3 before its conversion site in rat hepatocytes. FEBS Lett. 1987;214:135–8.
Pelham HRB. Sorting and retrieval between the endoplasmic reticulum and Golgi apparatus. Curr Opin Cell Biol. 1995;7:530–5.
Polizotto RS, de Figueiredo P, Brown WJ. Stimulation of Golgi membrane tubulation and retrograde trafficking to the ER by phospholipase A2 activating protein (PLAP) peptide. J Cell Biochem. 1999;74:670–83.
Price SC, Chescoe D, Grasso P, Wright M, Hinton RH. Alterations in the thyroids of rats treated for long periods with di-(2-ethylhexyl) phthalate or with hypolipidaemic agents. Toxicol Lett. 1988;40:37–46.
Robinson MS, Kreis T. Recruitment of coat proteins onto Golgi membranes in intact and permeabilized cells: effects of brefeldin A and G-protein activators. Cell. 1992;69:129–38.
Rothman JE. Mechanisms of intracellular protein transport. Nature. 1994;372:55–63.
Sciaky N, Presley J, Smith C et al. Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J Cell Biol. 1997;139:1137–55.
Springer S, Spang A, Schekman R. A primer on vesicle budding. Cell. 1999;97:145–8.
Storrie B, White J, Rottger S, Stelzer EH, Suganuma T, Nilsson T. Recycling of Golgi-resident glycosyltransferases through the ER reveals a novel pathway and provides an explanation for nocodazole-induced Golgi scattering. J Cell Biol. 1998;143:1505–21.
Thyberg J, Moskalewski S. Microtubules and the organization of the Golgi complex. Exp Cell Res. 1985;159:1–16.
Ulmer JB, Palade GE. Targeting and processing of glycophorins in murine erythroleukemia cells: use of brefeldin A as a perturbant of intracellular traffic. Proc Natl Acad Sci USA. 1989;86:6992–6.
Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 1999;369:11–23.
Wong DH, Brodsky FM. 100-kD proteins of Golgi and trans-Golgi network-associated vesicles have related but distinct membrane binding properties. J Cell Biol. 1992;117:1171–9.
Wood SA, Park JE, Brown WJ. Brefeldin A causes a microtubule-mediated fusion of the trans Golgi network and early endosomes. Cell. 1991;67:591–600.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Figueiredo, P., Brown, W. Clofibrate inhibits membrane trafficking to the Golgi complex and induces its retrograde movement to the endoplasmic reticulum. Cell Biol Toxicol 15, 311–323 (1999). https://doi.org/10.1023/A:1007667802497
Issue Date:
DOI: https://doi.org/10.1023/A:1007667802497